ENDRA Life Sciences (NDRA) Cost of Revenue (2016 - 2021)
Historic Cost of Revenue for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to $382113.0.
- ENDRA Life Sciences' Cost of Revenue rose 9857.87% to $382113.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.1 million, marking a year-over-year increase of 8480.65%. This contributed to the annual value of $571040.0 for FY2024, which is 3040.8% down from last year.
- Per ENDRA Life Sciences' latest filing, its Cost of Revenue stood at $382113.0 for Q4 2021, which was up 9857.87% from $275565.0 recorded in Q3 2021.
- ENDRA Life Sciences' Cost of Revenue's 5-year high stood at $382113.0 during Q4 2021, with a 5-year trough of $1124.0 in Q1 2017.
- For the 5-year period, ENDRA Life Sciences' Cost of Revenue averaged around $125312.5, with its median value being $111066.0 (2018).
- In the last 5 years, ENDRA Life Sciences' Cost of Revenue plummeted by 7464.47% in 2017 and then surged by 943532.03% in 2018.
- Over the past 5 years, ENDRA Life Sciences' Cost of Revenue (Quarter) stood at $3085.0 in 2017, then skyrocketed by 1259.09% to $41928.0 in 2018, then soared by 298.47% to $167070.0 in 2019, then rose by 15.18% to $192424.0 in 2020, then soared by 98.58% to $382113.0 in 2021.
- Its last three reported values are $382113.0 in Q4 2021, $275565.0 for Q3 2021, and $256763.0 during Q2 2021.